Ibrutinib Deacryloylpiperidine CAS 330786-24-8 Tsafta > 99.0% (HPLC)

Takaitaccen Bayani:

Sunan Chemical: Ibrutinib Deacryloylpiperidine

Saukewa: 330786-24-8

Tsafta:> 99.0% (HPLC)

Bayyanar: Kashe-White zuwa Khaki Foda

Matsakaicin Ibrutinib (CAS: 936563-96-1) 

Tuntuɓi: Dr. Alvin Huang

Wayar hannu/Wechat/WhatsApp: +86-15026746401

E-Mail: alvin@ruifuchem.com


Cikakken Bayani

Samfura masu dangantaka

Tags samfurin

Bayani:

Abubuwan Sinadarai:

Sunan Sinadari 3- (4-Phenoxyphenyl) -1H-pyrazolo [3,4-d] pyrimidin-4-amin
Makamantu Ibrutinib tsaka-tsakin N-2;Ibrutinib Deacryloylpiperidine;Ibrutinib rashin tsarki 8;5- (4-Phenoxyphenyl) -7H-pyrrolo [2,3-d] pyrimidin-4-ylamine;IBT4A;Ibrutinib N-Despiperidinyl rashin tsarki
Lambar CAS 330786-24-8
Matsayin Hannun jari A cikin Hannun jari, Ma'aunin samarwa Har zuwa Ton
Tsarin kwayoyin halitta Saukewa: C17H13N5O
Nauyin Kwayoyin Halitta 303.32
Matsayin narkewa > 262 ℃ (Dec.)
Yawan yawa 1.380± 0.06 g/cm3
Matsayin Hazard 6.1;Guba
Rukunin tattarawa III
COA & MSDS Akwai
Asalin Shanghai, China
Alamar Ruifu Chemical

Ƙayyadaddun bayanai:

Abu Ƙayyadaddun bayanai
Bayyanar Kashe-White zuwa Khaki Foda
Ganewa HNMR, LC-MS
Tsarkake / Hanyar Bincike > 99.0% (HPLC)
Asara akan bushewa <1.00%
Single Max.Rashin tsarki <1.00%
Jimlar ƙazanta <1.00%
Karfe masu nauyi (kamar Pb) <20ppm
Matsayin Gwaji Matsayin Kasuwanci
Amfani Matsakaicin Ibrutinib (CAS: 936563-96-1)

Kunshin & Ajiya:

Kunshin: Bottle, Aluminum tsare jakar, 25kg / Kwali Drum, ko bisa ga abokin ciniki ta bukata.

Yanayin Ajiya:Ajiye a cikin kwantena da aka rufe a wuri mai sanyi da bushe;Kare daga haske da danshi.

Amfani:

1

FAQ:

www.ruifuchem.com

330786-24-8 - Aikace-aikace:

3- (4-Phenoxyphenyl) -1H-pyrazolo [3,4-d] pyrimidin-4-amine (CAS: 330786-24-8) shine tsaka-tsaki na roba mai amfani a cikin kira na Ibrutinib (CAS: 936563-96-1). ).Ibrutinib wani nau'i ne na mai hana Bruton tyrosine kinase (BTK), ana iya amfani dashi don maganin cutar sankarar lymphocytic na kullum (CLL) da lymphoma na mantle cell (MCL).MCL da CLL na cikin ƙwayoyin lymphoma na B-cell ba Hodgkin ba, wanda ke da wuyar warkewa kuma yana da sauƙin maimaitawa.Maganin rigakafi na gama gari ba shi da niyya, sau da yawa yana faruwa 3 ko 4 munanan halayen.Ibrutinib da B lymphocytes na iya yin niyya tare da BTK wanda ya zama dole don samuwar, bambance-bambance, da watsa bayanai, hana ayyukan BTK ba tare da juyewa ba, kuma yana hana yaduwar ƙwayar ƙwayar cuta da rayuwa yadda ya kamata.Ibrutinib zai iya zama da sauri a sha bayan gudanarwa ta baki, a lokacin 1 ~ 2h ya kai matsakaicin maida hankali na jini, mummunan halayen na ɗaya ko biyu, sabili da haka, Ibrutinib zai zama sabon zaɓi na jiyya na CLL da MCL.

Ku rubuta sakonku anan ku aiko mana